Latest News for: chosa

Edit

CHOSA receives 94 tumour samples from US patients to validate Platin-DRP in lung cancer chemo-immunotherapy (Chosa Oncology AB)

Public Technologies 08 Oct 2026
) CHOSA receives 94 tumour samples from US patients to validate Platin-DRP® in lung cancer chemo-immunotherapy ... said Peter Buhl Jensen, CEO of CHOSA Oncology ... peter@chosa.bio + 45 21 60 89 22. About CHOSA Oncology AB.
Edit

CHOSA: Members of executive management participate in the ongoing warrant - exercise ending tomorrow (Chosa Oncology AB)

Public Technologies 13 Jul 2026
2026-07-13 17.17.21 CHOSA Oncology AB ... In the second quarter of 2025, CHOSA Oncology AB (publ) ("Chosa" or the "Company") issued 7,951,740 warrants of series TO2 in connection with an issue of units ... peter@chosa.bio.
Edit

Members of executive management participate in the ongoing warrant - exercise ending tomorrow (Chosa Oncology AB)

Public Technologies 13 Jul 2026
In the second quarter of 2025, CHOSA Oncology AB (publ) ("Chosa" or the "Company") issued 7,951,740 warrants of series TO2 in connection with an issue of units ... peter@chosa.bio ... About Chosa Oncology AB (publ).
Edit

CHOSA: CHOSA Oncology appoints US commercialization Bill Cronin with a broad network in the oncology market, to accelerate launch of Platin-DRP (Chosa Oncology AB)

Public Technologies 10 Jul 2026
2026-07-10 08.30.00 CHOSA Oncology AB ... 10th July 2026 - CHOSA Oncology AB ("CHOSA" or the "Company") today announces the appointment of Bill Cronin to support the Company''s commercial expansion in the United States.
  • 1

Article Search

tools
×
×
×
×